Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes.

It offers CanGaroo Envelope, which is used for the stabilization of implantable cardiac devices, such as pacemakers and defibrillators.

The company also engages in the development of CanGaroo RM for delivery directly to the surgical site.

In addition, it offers SimpliDerm Acellular Dermal Matrix used primarily in breast reconstruction following mastectomy.

The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023.

Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.